GH NASDAQ
Guardant Health, Inc.
1W: +9.6%
1M: +2.7%
3M: +19.9%
YTD: +79.5%
1Y: +157.7%
3Y: +612.4%
5Y: +73.8%
$182.59
+4.53 (+2.54%)
Weekly Expected Move ±7.0%
$146
$157
$169
$181
$193
Credit Risk of going bust: lower than 59% of companies Debt: 6.6% of company value Bonds: $181.2M held by 51 funds → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.31 (down 99.3%), Guardant Health, Inc. would be worth roughly what it owes.
Total debt $1.70B against a stock market value of $23.89B.
Distance to default 6.14 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $751.5M (short-term plus half of long-term), stock volatility 56.8%; Altman Z'' -3.67. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $1.31 (down 99.3%), Guardant Health, Inc. would be worth roughly what it owes.
Total debt $1.70B against a stock market value of $23.89B.
Distance to default 6.14 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $751.5M (short-term plus half of long-term), stock volatility 56.8%; Altman Z'' -3.67. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (100)
Guardant Health, Inc. (NASDAQ:GH) Stock Has Average Price Target of $190.00
Natera Partners With TransCode to Advance Colorectal Cancer Trial
Cathie Wood's weekly recap: adds to CoreWeave, Meta, Recursion; cuts Personalis, Toast
Guardant Health loses challenge regarding DNA sequencing patent
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Cathie Wood’s Ark weekly recap: cuts SpaceX exposure alongside HOOD, TER, boosts CRWV, VCYT
13,833 Guardant Health, Inc. $GH Shares Sold by NewEdge Advisors LLC
GRAIL sets new 52-week high as FDA panel backs cancer test
Cathie Wood's weekly recap: buys $25M of CoreWeave, trims $40M in Bitcoin ETF
Guardant Health (NASDAQ:GH) Director Sells $144,550.00 in Stock
10 large and mega-cap U.S. healthcare stocks with the strongest momentum grades
These large-cap U.S. stocks have the strongest momentum grades
Guardant Health (NASDAQ:GH) Hits New 52-Week High – Time to Buy?
Amundi Raises Position in Guardant Health, Inc. $GH
Hsbc Holdings PLC Grows Stock Holdings in Guardant Health, Inc. $GH
Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI
AstraZeneca wins approval of camizestrant for breast cancer
Ten healthcare stocks leading in year-over-year CapEx growth
Why Rule Breakers Buy a Stock That's Already "Won"
Bamco Inc. NY Makes New $2.48 Million Investment in Guardant Health, Inc. $GH
VCYT Drops 25.3% in the Past Month. Is the Sell-Off an Opportunity?
Callan Family Office LLC Invests $912,000 in Guardant Health, Inc. $GH
Corcept, Revolution Medicines lead ten large-cap healthcare stocks surging in 2026
Cetera Investment Advisers Has $1.12 Million Holdings in Guardant Health, Inc. $GH
Tempus AI's FDA Win Could Unlock Major Reimbursement Growth Ahead
Is Tempus AI Worth Buying as Growth Improves but Valuation Stays High?
Executive Dumps Over 14,000 Shares of Biotech Stock, Valued at $2.3 Million
Empowered Funds LLC Trims Stock Position in Guardant Health, Inc. $GH
Dimensional Fund Advisors LP Sells 123,826 Shares of Guardant Health, Inc. $GH
Guardant Health (GH) Q2 2026 Earnings Call Transcript
Guardant Health, Inc. Q2 2026 Earnings Call Summary
Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates
Guardant Health (GH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
TG Therapeutics (TGTX) to Report Q2 Results: Wall Street Expects Earnings Growth
Caxton Associates LLP Invests $831,000 in Guardant Health, Inc. $GH
Guardant Health, Inc. $GH Shares Sold by Atika Capital Management LLC
Guardant Health (GH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Amova Asset Management Americas Inc. Sells 156,738 Shares of Guardant Health, Inc. $GH
Guardant Health, Inc. (NASDAQ:GH) Receives $155.70 Average Price Target from Analysts
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
When Multi-Cancer Blood Screens Could Finally Take Off
Guardant Health Stock Climbs As Analysts Hike Targets - timothysykes.com
Guardant Health (GH) files to resell 4,000 shares via cashless option exercise - Stock Titan
Guardant Health Stock Climbs As Wall Street Targets Surge - StocksToTrade
$GH stock is up 13% today. Here's what we see in our data. - Quiver Quantitative
UnitedHealth Group Now Covers Guardant Health’s Shield Blood Test for Colorectal Cancer Screening
UnitedHealth Group Now Covers Guardant Health’s Shield Blood Test for Colorectal Cancer Screening - Stock Titan
GH Maintained by BTIG -- Price Target Raised to $190 - GuruFocus
GH Stock At Over 5-Year Highs – What’s The UnitedHealth Connection? - Yahoo Finance
GH Stock At Over 5-Year Highs – What’s The UnitedHealth Connection?
GH Stock At Over 5-Year Highs – What’s The UnitedHealth Connection? - Stocktwits
Guardant Health (GH) Shares Rise After UnitedHealth Coverage Ann - GuruFocus
Guardant Health (GH) Gains from United Healthcare Coverage Expan - GuruFocus
Guardant Health (GH) Sees Share Price Surge Following UnitedHeal - GuruFocus
Guardant Health Stock Rises As FDA And Wall Street Back Growth Story - StocksToTrade
3 Mid-Cap Stocks We’re Skeptical Of
3 Mid-Cap Stocks We’re Skeptical Of - StockStory
Guardant Health (GH) co-CEO sells 260K shares after option exercises - Stock Titan
Guardant Health Stock 5-Day Winning Spree: Stock Climbs 19% - Trefis
Guardant Health Stock Surges 19%, With A 5-Day Winning Spree - Trefis
Guardant Health (GH) Stock After 193% One-Year Gain Is The Rally Running Out Of Room - simplywall.st
Why Are Guardant Health (GH) Shares Soaring Today
Why Are Guardant Health (GH) Shares Soaring Today - Yahoo Finance
Dow Jones Futures Rise As Micron Earnings Send Sandisk, Techs Soaring; Fed Inflation Data Due
Guardant Health stock climbs as investors continue to digest screening and diagnostics catalysts - Quiver Quantitative
Dow Jones Futures: Nasdaq Set To Regain Key Level As Korea's Kospi Rebounds, Micron Due; FedEx, Cerebras Tumble
3 Russell 2000 Stocks We Approach with Caution
Living Longer Is Big Business. These Stocks Will Benefit.
Guardant rated new Outperform at RBC on catalysts, growth prospects
Guardant Health Announces FDA Approval of Guardant360 CDx as Companion Diagnostic for Boehringer Ingelheim’s HERNEXEOS®
Why Grail Could Be the Sleeper Stock Everyone's About to Notice
How The Guardant Health (GH) Investment Story Is Evolving As Expectations Stay Unchanged
1 Cash-Burning Stock with Promising Prospects and 2 Facing Headwinds
1 Unpopular Stock That Should Get More Attention and 2 We Find Risky
Here's Why This Colon Cancer Testing Biotech Is A Mutual Fund Favorite
3 Reasons GH is Risky and 1 Stock to Buy Instead
3 Unprofitable Stocks Walking a Fine Line
Testing & Diagnostics Services Stocks Q1 Earnings: Guardant Health (NASDAQ:GH) Firing on All Cylinders
Liquidia is the best performing healthcare stock in the past month
Guardant Health Just Broke Out On Bullish News For Its Colon Cancer-Detecting Blood Test
D-Wave, Dell, And IonQ Are Among Top 10 Large-Cap Gainers Last Week (May 18-May 22): Are the Others in Your Portfolio?
Guardant Health Secures FDA Approval For Expanded Liquid Biopsy Test
Guardant Health (GH) Q1 2026 Earnings Transcript
Guardant Health CMO resigns
Guardant Health raises 2026 revenue outlook to $1.30B-$1.32B as Shield targets 230,000-245,000 tests
Compared to Estimates, Guardant Health (GH) Q1 Earnings: A Look at Key Metrics
Guardant Health (GH) Reports Q1 Loss, Beats Revenue Estimates
Guardant Health Non-GAAP EPS of -$0.45 beats by $0.02, revenue of $301.7M beats by $22.64M
Urogen Pharma (URGN) Reports Q1 Loss, Beats Revenue Estimates
Repligen (RGEN) Q1 Earnings and Revenues Beat Estimates
Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind Breast Cancer Therapy
William Blair updates conviction stock list
Pfizer, Arvinas breast cancer therapy approved by the FDA
Guardant Health (GH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Why Is Guardant Health Stock Falling On Tuesday?
B. Metzler seel. Sohn & Co. AG Takes Position in Guardant Health, Inc. $GH
Guardant Health, Inc. $GH Shares Acquired by Assetmark Inc.
Guardant Health, Inc. $GH Holdings Lowered by Baillie Gifford & Co.
Cloudflare, ServiceNow, And Guardant Health Are Among Top 10 Large-Cap Losers Last Week (April 6-April 10): Are the Others in Your Portfolio?
Guardant Health (NASDAQ:GH) Trading Down 7% – Here’s What Happened